1.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwidefor 36 Cancers in 185 Countries CA: A Cancer Journal forClinicians 2021; 71: 209-249.
2.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, OsteenR. Cancer of the stomach. A patient care study by the AmericanCollege of Surgeons. Ann Surg 1993; 218: 583-92.
3.
Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastriccancer: a 25-year review. British J Surg 1989; 76: 535-40.
4.
Kim MM, Rana V, Janjan NA, et al. Clinical benefit of palliativeradiation therapy in advanced gastric cancer. Acta Oncologica2008; 47: 421-27.
5.
Hashimoto K, Mayahara H, Takashima A, et al. Palliativeradiation therapy for hemorrhage of unresectable gastric cancer:a single institute experience. J Cancer Res Clin Oncol 2009; 135:1117-23.
6.
Lee JA, Lim DH, Park W, Ahn YC, Huh SJ. Radiation therapy forgastric cancer bleeding. Tumori 2009; 95: 726-30.
7.
Asakura H, Hashimoto T, Harada H, et al. Palliative radiotherapyfor bleeding from advanced gastric cancer: is a schedule of 30Gy in 10 fractions adequate? J Cancer Res Clin Oncol 2011; 137:125-30
8.
Chaw CL, Niblock PG, Chaw CS, Adamson DJ. The role ofpalliative radiotherapy for haemostasis in unresectable gastriccancer: a single-institution experience. Ecancermedicalscience2014; 8: 384.
9.
Tey J, Choo BA, Leong CN, et al. Clinical outcome of palliativeradiotherapy for locally advanced symptomatic gastric cancer inthe modern era. Medicine 2014; 93: e118.
10.
Kondoh C, Shitara K, Nomura M, et al. Efficacy of palliativeradiotherapy for gastric bleeding in patients with unresectableadvanced gastric cancer: a retrospective cohort study. BMCPalliat Care 2015; 14: 37.
11.
Takeda K, Sakayauchi T, Kubozono M, et al. Palliativeradiotherapy for gastric cancer bleeding: a multi-institutionalretrospective study. BMC Palliat Care 2022; 21: 52.
12.
Mitsuhashi N, Ikeda H, Nemoto Y, Kuronuma M, Kamiga M,Hiroshima Y. Hemostatic effect of palliative radiation therapy inpreventing blood transfusions from bleeding occurring withinadvanced gastric cancer. Palliat Med Rep 2021; 2: 355-64.
13.
Kim YI, Choi IJ. Endoscopic management of tumor bleedingfrom inoperable gastric cancer. Clin Endosc 2015; 48: 121-7.
14.
Kamarajah SK, Markar SR, Phillips AW, Salti GI, DahdalehF, Griffiths EA. Palliative gastrectomy for metastatic gastricadenocarcinoma: a national population-based cohort study.Surgery 2021; 170: 1702-10.
15.
Manfredi S, Dior M, Bouche O, et al. Daily practices inchemotherapy for advanced gastric or gastroesophageal junctionadenocarcinoma: METESTOMAC French prospective cohort.Cancer Med 2022; 10: 1002.
16.
Halpern AL, McCarter MD. Palliative management of gastric andesophageal cancer. Surg Clin North Am 2019; 99: 555-69.
17.
Lee YH, Lee JW, Jang HS. Palliative external beam radiotherapyfor the treatment of tumor bleeding in inoperable advancedgastric cancer. BMC Cancer 2017; 17: 541.
18.
Tey J, Soon YY, Koh WY et al. Palliative radiotherapy for gastriccancer: a systematic review and meta-analysis. Oncotarget 2017;8: 25797-805
19.
Inoue T. Successful palliative radiotherapy for malignant cardiacobstruction caused by gastric cancer. Cureus 2022; 14: e27466.
20.
Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy oflocally advanced esophageal cancer: long-term follow-up of aprospective randomized trial (RTOG 85-01). Radiation TherapyOncology Group. JAMA 1999; 281: 1623-7.
21.
Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapyand radiotherapy compared with radiotherapy alone in patientswith cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
22.
Penniment MG, De Ieso PB, Harvey JA, et al. Palliativechemoradiotherapy versus radiotherapy alone for dysphagiain advanced oesophageal cancer: a multicentre randomisedcontrolled trial (TROG 03.01). Lancet Gastroenterol Hepatol2018; 3: 114-124.